Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001493152-20-019587
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-10-16 21:30:09
Reporting Period:
2020-10-16
Accepted Time:
2020-10-16 21:30:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1710340 Eton Pharmaceuticals Inc. ETON () MA
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1595855 Opaleye Management Inc. One Boston Place, 26Th Floor
Boston MA 02108
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.001 Per Share Acquisiton 2020-10-16 385,000 $7.00 3,885,000 No 4 P Indirect By Opaleye, L.P.
Common Stock, Par Value $0.001 Per Share Acquisiton 2020-10-16 15,000 $7.00 155,000 No 4 P Indirect By Managed Account
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Opaleye, L.P.
No 4 P Indirect By Managed Account
Footnotes
  1. Represents securities owned directly by Opaleye, L.P. (the "Fund"). As the investment manager of the Fund, Opaleye Management Inc. may be deemed to beneficially own the securities owned directly by the Fund.
  2. Securities owned by a separately managed account (the "Managed Account"). As the portfolio manager of the Managed Account, Opaleye may be deemed to beneficially own the securities owned directly by the Managed Account.